Schizophrenia Trial, Recruiting NCT05340348 Sponsor: University Hospital, Brest Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT05340348
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 15 to 30 who have been assessed at the CEVUP clinic (a specialist clinic for psychological vulnerability) and are receiving care at a psychiatry centre following a first episode of psychosis (their first hospitalisation for this)
  • People who have been referred to the clinic by a health or social care professional, such as a GP, school doctor, school nurse, educator, addiction specialist, or psychiatrist
  • People whose assessment results place them in an "at risk" category for psychotic disorder, or who have reached a psychosis threshold, based on a specific clinical test called the CAARMS (a tool used to measure psychotic symptoms)
  • People (or their legal guardian, if applicable) who have given consent to take part in the trial

Who may not be able to join:

  • People who have had a history of psychosis lasting more than one year
  • People whose CAARMS assessment results show they are "not at risk" for psychotic disorder
  • People with an IQ below 70, as measured by a standard intelligence assessment (WAIS)
  • People whose symptoms are better explained by a neurological condition or another health problem
  • People who do not wish to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michel WALTER, CHRU BREST

Phone: +332 98 01 51 56

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Brest
Registry
ClinicalTrials.gov
Start date
25 July 2022
Est. completion
25 July 2032

Where this trial is recruiting

🇫🇷 France

Primary endpoints

CAARMS (Comprehensive assessment of at-risk mental states) score.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov